Forging the Future of Global Health

About us
Kashiv's Lab Imagery
Company Overview

Creating a Healthier World through Accessible Biologics

Kashiv BioSciences, LLC is a fully-integrated biopharmaceutical company. Kashiv BioSciences, LLC in the United States, and its subsidiary, Kashiv BioSciences Private Limited in India (together “Kashiv BioSciences”) operate together with robust infrastructure and highly skilled teams that provide global R&D, clinical, manufacturing, regulatory, and IP capabilities. We believe our people, partners, and shared purpose fuel our work to advance patient care and      access to important medicines."



Combined facility
square footage





We are fully dedicated tothe promise of biosimilars. We lead with science to accelerate development and drive manufacturing efficiency.


To become the trusted choice of high-quality, affordable biosimilars for patients worldwide.
executive leadership

Highly experienced team

The company’s scientific and business executives have extensive industry experience in developing a wide range of small and large molecules and creating high-value enterprises.
AriseHealth logoOE logo2020INC logoThe Paak logoEphicient logoToogether logo

What we look for?

We are seeking commercialization partners for our internally developed products globally through licensing, strategic partnering, or profit-sharing joint ventures at meaningful development inflection points.
To continue expanding our biosimilars pipeline, we are also evaluating in-licensing opportunities for biosimilars that have completed analytical similarity testing with innovator-branded biologics for global development.

Let's Work Together!

Dr. Paras Vasanani
Head of BD&L, Portfolio Strategy
World Map

Infrastructure summary

Global integrated infrastructure together enables end-to-end global R&D, regulatory, and manufacturing capabilities.

Piscataway, New Jersey

Kashiv BioSciences’ 50,000 sq. ft. R&D facility has capabilities for mammalian cell line development, advanced analytical characterization, bioassay development, and small-scale manufacturing of complex proteins and monoclonal antibodies.
Analytical Characterization Lab
Cell Line Process Development
Biosimilar R&D Facility

Chicago, Illinois

Kashiv BioSciences’ 100,000 sq.ft. R&D and manufacturing facility has capabilities for development and manufacturing of commercial-scale microbial cell lines, drug substance, and a fill and finish line for prefilled syringes and vials. It is an FDA-registered site and complies fully with Local, State, and Federal Agencies, OSHA, EPA, and cGMP Standards.
Upstream Production Suite
Injectable Fill and Finish Line
Biosimilar R&D and Injectable Manufacturing Facility

Ahmedabad, Gujarat, India

Kashiv BioSciences Private Limited's 125,000 sq.ft. R&D facility contains state-of-the-art analytical labs for characterization, stability, bioassay development, process development, and small scale manufacturing of complex proteins for biosimilars.
India office and R&D facility
Biosimilars, 505(b)(2), and prodrug development
Analytical labs equipped with the latest technology